Biotech Stocks Surge as Small-Cap Market Sees Record Gains
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – July 18, 2025
The Nasdaq Biotech and small-cap markets saw broad-based advances on July 18, with most names posting double-digit gains amid heavy trading volumes. A handful of companies more than doubled on specific news events and technical triggers, driving an uptick in overall market momentum. Below is a summary of key movers and volume leaders.
Trading Summary
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| MEIP | 3.3277 | 5.7385 | 23,532,962 | 72.41% |
| YHC | 1.6424 | 2.2800 | 6,278,900 | 38.86% |
| TELO | 1.4085 | 2.1400 | 64,399,365 | 51.96% |
| CPOP | 0.4874 | 0.7330 | 15,840,472 | 50.43% |
| LAWR | 2.6618 | 3.6900 | 9,642,671 | 38.68% |
| BTOG | 0.5220 | 0.7426 | 228,458,020 | 42.25% |
| BKSY | 21.1307 | 23.8000 | 5,508,018 | 12.60% |
| DPRO | 4.8541 | 5.5600 | 11,523,649 | 14.56% |
| BZAI | 3.5387 | 4.6600 | 39,658,821 | 31.72% |
| TDTH | 0.9790 | 1.4100 | 16,945,193 | 44.07% |
| OPEN | 1.6648 | 2.3150 | 384,853,317 | 39.20% |
| IXHL | 0.3786 | 0.5980 | 354,286,551 | 57.96% |
| LDI | 1.6835 | 1.8800 | 2,268,030 | 11.67% |
| WGRX | 0.5079 | 0.9601 | 22,041,178 | 89.09% |
| CYCC | 5.2222 | 11.7500 | 15,446,632 | 125.00% |
| AIRE | 0.1443 | 0.1980 | 33,239,543 | 37.11% |
| STEM | 9.0954 | 13.7100 | 2,410,170 | 50.74% |
| PTNM | 0.4203 | 2.1500 | 3,010,419 | 411.48% |
ATTN Price is the implied previous close based on today’s % change.
Market Trends and Patterns
Trading volumes were notably elevated across small-cap biotech and technology stocks, reflecting renewed investor interest in speculative setups and pending data catalysts. Of the 18 securities tracked, all posted gains, with an average advance of approximately 66%. The strength was broad, but skewed toward sub-$5 names, suggesting a rotation into higher-beta, momentum-driven issues.
Intraday patterns showed early consolidation in most tickers, followed by midday breakouts that propelled prices toward their session highs. Heavy volume spikes accompanied these breakouts, indicating institutional or algorithmic participation.
Biotech Gains by CDC
Notable Movers and Volume Surges
- PTNM (↑411.48%) saw the largest relative advance after a strategic partnership announcement. Although liquidity remained modest by dollar value, the volume surge of 3.0 million shares was five times its 30-day average.
- CYCC (↑125.00%) doubled on news of a license agreement and subsequent secondary offering to fund Phase 2 trials. Volume ran 50% above its recent norm.
- WGRX (↑89.09%) climbed on the launch of an XRP payment integration, drawing retail buyers; 22 million shares traded, aligning with its multi-month high in turnover.
- IXHL (↑57.96%) and TELO (↑51.96%) both rallied on upcoming clinical data readouts, trading in excess of 350 million and 64 million shares, respectively.
Meanwhile, several mid-range gainers such as MEIP, STEM, and BZAI rallied 30–70% on strategic updates and trial enrollment progress, each accompanied by notable volume upticks.
TL;DR
- Broad-based gains in small-cap biotech/tech stocks; all 18 tracked names advanced.
- Average price increase: ~66%; average volume spike: ~2× normal.
- Top movers: PTNM (+411%), CYCC (+125%), WGRX (+89%), IXHL (+58%).
- Heavy flows into momentum plays ahead of clinical and tech-integration catalysts.